Molecular modelling to help create better, safer drugs
How our bodies break down the common drugs ibuprofen, diclofenac and warfarin is the subject of a new study from the University of Bristol, published in the Journal of the American Chemical Society. The research should ultimately help predict how new drugs will be metabolized in the body, potentially helping avoid adverse drug reactions in future.
Source: University of Bristol news - Category: Universities & Medical Training Authors: news_text Tags: Press releases Source Type: news
More News: Chemistry | Coumadin | Diclofenac | Drugs & Pharmacology | Ibuprofen | Study | Universities & Medical Training | Voltaren | Warfarin